Identification and Characterization of Novel FSHR Copy Number Variations Causing Premature Ovarian Insufficiency
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63924 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Anna Lokchine und 14 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S1085, Rennes, France. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Receptors, FSH, DNA Copy Number Variations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Follicle stimulating hormone (FSH) is a key pituitary gonadotropic hormone implicated in human fertility and is crucial for folliculogenesis and recruitment of new antral follicles. Variations in its receptor, FSHR, can lead to diverse reproductive phenotypes including ovarian hyperstimulation syndrome (OHSS) and premature ovarian insufficiency (POI). This study reports a novel case of FSHR‐related ovarian insufficiency in a patient with primary amenorrhea, subnormal AMH levels, and delayed puberty. Genetic exploration revealed two compound heterozygous intragenic deletions of FSHR. Specifically, the patient inherited a maternally derived deletion spanning exons 5–10 and a paternally derived deletion involving exons 3–6. Through chromosomal microarray analysis (CMA), exome sequencing, long‐range PCR, and Sanger sequencing, we characterized the breakpoints and confirmed the compound heterozygous deletions. The findings reveal a complete loss of function of both FSHR alleles, contributing to the patient's POI phenotype. This case emphasizes the complexity of genotype–phenotype correlations in FSHR‐related disorders and the role of CNVs in POI phenotypes. Although these events are rare, our results advocate for the inclusion of CNV detection in the diagnostic workup of POI to ensure accurate diagnosis and better patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S1085, Rennes, France.
- CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, Rennes, France.
- Service de Génétique Moléculaire et de Cytogénomique, CHU de Montpellier, Montpellier, France.
- PhyMedExp, Université de Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
- CHU Rennes, Service de Génétique Clinique, CLAD Ouest, Rennes, France.
- CHU Rennes, Département de Gynécologie Obstétrique et Reproduction Humaine, Rennes, France.
ORCID-Profile: Anna Lokchine, Laura Mary
Zitieren
APA
Lokchine, A., Bergougnoux, A., Servant, N., Akloul, L., Launay, E., Mary, L., Cluzeau, L., Philippe, M., Domin-Bernhard, M., Duros, S., Odent, S., Tucker, E., Paris, F., Belaud-Rotureau, M. A., & Jaillard, S. (2025). Identification and Characterization of Novel FSHR Copy Number Variations Causing Premature Ovarian Insufficiency. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63924
Vancouver
Lokchine A, Bergougnoux A, Servant N, Akloul L, Launay E, Mary L, et al. Identification and Characterization of Novel FSHR Copy Number Variations Causing Premature Ovarian Insufficiency. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63924
BibTeX
@article{Lokchine2025,
author = {Lokchine, Anna and Bergougnoux, Anne and Servant, Nadège and Akloul, Linda and Launay, Erika and Mary, Laura and Cluzeau, Laurence and Philippe, Mathieu and Domin-Bernhard, Mathilde and Duros, Solène and Odent, Sylvie and Tucker, Elena and Paris, Françoise and Belaud-Rotureau, Marc-Antoine and Jaillard, Sylvie},
title = {Identification and Characterization of Novel FSHR Copy Number Variations Causing Premature Ovarian Insufficiency},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63924}
}
EUVIMED